Biogen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,009	2,375	1,050	3,419	2,261
Short-Term Investments	807.2	-	-	1,474	1,541
Cash & Short-Term Investments	3,816	2,375	1,050	4,893	3,803
Cash Growth	60.66%	126.21%	-78.54%	28.67%	45.68%
Accounts Receivable	1,867	1,869	2,100	2,136	1,962
Other Receivables	-	-	430	798.8	-
Receivables	1,867	1,869	2,530	2,935	1,962
Inventory	2,168	2,461	2,527	1,344	1,352
Prepaid Expenses	693.6	307.2	-	-	-
Other Current Assets	429.7	445.3	752	618.8	740.8
Total Current Assets	8,974	7,457	6,859	9,791	7,857
Property, Plant & Equipment	3,321	3,538	3,730	3,703	3,792
Long-Term Investments	954.5	423.8	625.8	1,776	2,826
Goodwill	6,491	6,479	6,219	5,749	5,761
Other Intangible Assets	9,179	9,691	8,363	1,850	2,221
Long-Term Deferred Tax Assets	292.5	324.2	928.6	1,226	1,415
Other Long-Term Assets	198	136.7	119.2	459.3	5.5
Total Assets	29,440	28,049	26,845	24,554	23,877
Accounts Payable	432	424.2	403.3	491.5	589.2
Accrued Expenses	1,679	1,504	1,453	1,497	1,382
Current Portion of Long-Term Debt	-	1,749	150	-	999.1
Current Portion of Leases	80.4	86.4	90.3	97.2	89.1
Current Income Taxes Payable	114.8	548.3	257.4	259.9	174.7
Other Current Liabilities	1,044	1,218	1,080	927.6	1,064
Total Current Liabilities	3,349	5,529	3,434	3,273	4,298
Long-Term Debt	6,287	4,547	6,788	6,281	6,274
Long-Term Leases	290.4	334.5	400	333	330.4
Long-Term Deferred Tax Liabilities	507.6	190.5	641.8	334.7	694.5
Other Long-Term Liabilities	748.5	732.3	781.1	944.2	1,321
Total Liabilities	11,183	11,333	12,045	11,166	12,918
Common Stock	0.1	0.1	0.1	0.1	0.1
Additional Paid-In Capital	863.1	569.4	302.5	73.3	68.2
Retained Earnings	20,553	19,260	17,628	16,467	13,912
Treasury Stock	-2,977	-2,977	-2,977	-2,977	-2,977
Comprehensive Income & Other	-182	-136.2	-153.7	-164.9	-106.7
Total Common Equity	18,257	16,716	14,799	13,398	10,896
Minority Interest	-	-	-	-9.5	63.5
Shareholders' Equity	18,257	16,716	14,799	13,388	10,960
Total Liabilities & Equity	29,440	28,049	26,845	24,554	23,877
Total Debt	6,658	6,717	7,429	6,711	7,693
Net Cash (Debt)	-2,410	-4,342	-6,379	-1,113	-2,998
Net Cash Per Share	-16.38	-29.76	-43.81	-7.62	-20.04
Filing Date Shares Outstanding	146.76	146.37	145.36	144.49	146.96
Total Common Shares Outstanding	146.8	145.8	144.9	144.1	147
Working Capital	5,625	1,928	3,425	6,518	3,558
Book Value Per Share	124.37	114.65	102.14	92.98	74.12
Tangible Book Value	2,587	545.9	217.2	5,799	2,914
Tangible Book Value Per Share	17.62	3.74	1.50	40.24	19.82
Land	216.7	202.4	202.4	202.4	207.5
Buildings	2,140	1,964	1,601	1,593	1,700
Machinery	2,230	2,169	1,765	1,673	1,653
Construction In Progress	163.1	308.4	975.4	888.8	770.3
Leasehold Improvements	143.5	137.8	135.7	107.7	121

Source: S&P Global Market Intelligence. Standard template. Financial Sources.